Pai Zhu
Angel Investor · at Yifeng Capital
Pai Zhu is a Series B investor at Yifeng Capital focused on Biotechnology and Genetics. Zhu Pai is the managing partner of Yifeng Capital.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 83%
Last updated:
For AI agents: llms.txt
Industries Pai Zhu invests in
Stages Pai Zhu invests in
Countries Pai Zhu invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 3 (50%)
- Genetics 2 (33%)
- Clinical Trials 2 (33%)
- Biopharma 1 (17%)
- Health Care 1 (17%)
Stage
- Series B 2 (33%)
- Seed 1 (17%)
- Series A 1 (17%)
- Series C 1 (17%)
- Venture - Series Unknown 1 (17%)
Country
- China 5 (83%)
- Japan 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan. | $13.8M / Venture - Series Unknown / Jun 12, 2024 | ||
| Century Kangtai is a Class III medical device manufacturer that combines production, research and development, and sales. Century Kangtai is a collagen material developer and ophthalmic clinical trial company. Its primary business is the research and development, production, and marketing of ocular implant devices, as well as the provision ofafter-sales services to consumers. It has computer numerical control air suspension and uses laser navigation technology and laser interference. Products that use measurement technology include integrated posterior chamber intraocular lenses, ocular fixation rings, and collagen sponges. | Series B / Sep 20, 2023 | ||
| Lingyi Bio is a rare disease animal model functional verification platform and gene therapy developer. | $14.5M / Series A / May 06, 2023 | ||
| Maijing Gene is a gene detection technology company that specializes in R&D, production, and sales of molecular diagnostic products. It is also committed to promoting the application of second-generation high-throughput sequencing technology in the field of precision medicine.Maijing Gene was established in 2015 and is based in Guangzhou,China. | Series C / Dec 29, 2022 | ||
| Beimei Pharmaceutical is a biotech company focusing on the research and deveopment of children's prescription drugs. | $15.7M / Series B / Apr 02, 2022 | ||
|
West Lake Omi
|
Westlake Omi combines proteomic big data with artificial intelligence, mass spectrometry-based biological sample digitization technology. | Seed / Jan 13, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Pai Zhu invest in?
Pai Zhu invests primarily in Biotechnology, Genetics and Clinical Trials startups, most often at Series B and Seed stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Pai Zhu?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Pai Zhu last invest?
The most recent investment recorded for Pai Zhu closed in Jun 2024. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
